Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC ; volume:24 ; number:1 ; day:23 ; month:5 ; year:2024 ; pages:1-13 ; date:12.2024
BMC pulmonary medicine ; 24, Heft 1 (23.5.2024), 1-13, 12.2024
- Creator
-
Mao, Zhirong
Pang, Guanchao
Huang, Xiaojie
Chen, Xiuxiu
Wu, Jiaji
Xu, Xia
Teng, Zhihua
Tan, Yanbin
Wang, Pingli
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-024-03041-6
- URN
-
urn:nbn:de:101:1-2408020950433.976798914066
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mao, Zhirong
- Pang, Guanchao
- Huang, Xiaojie
- Chen, Xiuxiu
- Wu, Jiaji
- Xu, Xia
- Teng, Zhihua
- Tan, Yanbin
- Wang, Pingli
- SpringerLink (Online service)
Other Objects (12)
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis
Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis
Checkpoint inhibitor pneumonitis: Short review of literature and case report
Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis
Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis
Checkpoint inhibitor pneumonitis: Short review of literature and case report
Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis
Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis
Checkpoint inhibitor pneumonitis: Short review of literature and case report